In hepatocytes from overnight-fasted rats incubated with glucose, palmitate decreased the production of lactate, the detritiation of [2-3H]-and [3-3H]-glucose, and the concentration of fructose 2,6-bisphosphate.
INTRODUCTION
In general, changes in glycolytic flux in liver are related to, and probably caused by, corresponding changes in fructose 2,6-bisphosphate (Fru-2,6-P2) concentration, except during anoxia (for recent reviews, see [1] and [2] ). For example, in isolated rat hepatocytes, the stimulation of glycolysis by glucose concentrations greater than 10 mm can be explained by an increase in Fru-2,6-P2, which itself results from a glucose-induced rise in fructose 6-phosphate concentration. Conversely, a decrease in Fru-2,6-P2 concentration is observed when hepatocytes are incubated in the presence of glucagon or when large concentrations of gluconeogenic precursors such as lactate, pyruvate, alanine, glycerol or fructose are added. The effect of glucagon results from the cyclic AMPdependent phosphorylation of 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase (FBPase-2). Phosphorylation inactivates PFK-2 and activates FBPase-2.
The effect of gluconeogenic precursors might be explained by an inhibition of PFK-2 activity and/or stimulation of FBPase-2 activity by intermediates such as phosphoenolpyruvate or sn-glycerol 3-phosphate, which accumulate under these conditions. Fatty acids and ketone bodies are known preferred substrates for heart and skeletal muscle, where their oxidation inhibits glucose utilization and thus allows for glucose sparing [3] [4] [5] . On the other hand, fatty acids are known to stimulate gluconeogenesis in liver [6, 7] , and one may wonder whether they inhibit liver glycolysis.
Our results show that this is the case and that a decrease in Fru-2,6-P2 is involved in this mechanism. The effect of palmitate in hepatocytes was compared with that of /-hydroxybutyrate in perfused hearts.
MATERIALS AND METHODS Biochemicals
Glucose, D-/J-hydroxybutyrate, sodium palmitate, bovine serum albumin fraction V (all from Sigma) and other biochemical reagents (Sigma or Boehringer) were purchased as indicated. Albumin was defatted [8] and complexed with palmitate as described [9] . Preparation and incubation of hepatocytes Hepatocytes were prepared from overnight-fasted male Wistar rats as described previously [10] . The cells (about 100 mg wet wt. in 2 ml) were shaken (120 strokes/ min) in stoppered 20 ml flasks at 37°C for 45 min with glucose and albumin-bound palmitate at the concentrations indicated, and in the presence of 02/C02 (19:1) . the measurement of enzyme activities and of Fru-2,6-P2, samples (0.1 ml) were taken after 30 min of incubation, addition of 0.2 ml of ice-cold concentrated HCI04. For the measurement of enzyme activities and of Fru-2,6-P2 samples (0.1 ml) were taken after 30 min of incubation, frozen in acetone/solid CO2 and further processed as indicated below. For the measurement of 3H20 release from [2-3H]-or [3-3H] -glucose (0.5,uCi/ml), 3H20 was separated from the radioactive glucose in neutralized HC104 extracts [11] . The release of 3H20 from [2-3H]-and [3-3H]-glucose gives an indirect estimation of the glucose flux through glucokinase and 6-phosphofructo-1 -kinase (PFK-1) respectively [12] . To measure the intracellular concentration of hexose 6-phosphate and sn-glycerol 3-phosphate [13] , the cells were separated from the incubation medium and deproteinized as described previously [14] . Assay of metabolites and enzyme activity Glucose 6-phosphate [16] , fructose 6-phosphate [16] , lactate [17] , citrate [18] , sn-glycerol 3-phosphate [19] and ATP [20] were determined enzymically in neutralized HC104 extracts, and Fru-2,6-P2 [21] was determined in alkaline extracts as described in the references. The activation state of PFK-2 from hepatocytes was determined as described previously [22] . For the study of PFK-2 inhibition by citrate, the liver and the heart enzyme were purified as described [23] , and the activity was assayed [24] at pH 7.1 in the presence of 0.3 mMglucose 6-phosphate, 0.1 mM-fructose 6-phosphate, 5 mMMgATP and 5 mM-potassium phosphate.
Perfusion of hearts

RESULTS
Inhibition of liver glycolysis by palmitate
Palmitate decreased the production of lactate, the flux through PFK-1 as measured by detritiation of [3-3H] glucose, and the concentration of Fru-2,6-P2 in hepatocytes incubated with various glucose concentrations ( Fig. 1 ). Both the sensitivity towards glucose and the-maximal rate of lactate release were decreased by palmitate. Thus, it appears that, like in muscle [5] , fatty acids are capable of inhibiting glycolysis. The inhibitory concentrations of palmitate (Fig. 2) correspond to fatty acids/albumin molar ratios of 0.9-4.5, which overlap the range of values in vivo (0.2-3). Therefore, the inhibitory effect reported is probably of physiological relevance. The effect of palmitate in liver glycolysis and Fru-2,6-P2 contrasts sharply with its effect in isolated adipocytes. In these cells, palmitate increased glucose detritiation without changing Fru-2,6-P2 concentration and lactate release [25] .
To understand the mechanism(s) involved in the inhibition of liver glycolysis by palmitate, metabolic fluxes and the concentrations of several effectors of PFK-I were measured (Table 1) . Palmitate was found to inhibit glucose phosphorylation, as measured by the detritriation of [2-3H] glucose. The inhibition was reflected by the small but significant fall in the intracellular concentration of hexose 6-phosphate. This effect of palmitate on glucose phosphorylation in intact cells is consistent with the inhibition of glucokinase in vitro by long-chain acyl-CoA [26] . However, glucokinase inhibition in intact cells cannot be solely responsible for the inhibition of glycolysis (Table 1, Fig. 1 ), since the decreases in lactate release and in PFK-1 flux were greater than the inhibition of glucose phosphorylation. The combined effect of decreased concentration of positive effector (Fru-2,6-P2) and increased concentration of negative effectors (citrate and-sn-glycerol 3 phosphate) of PFK-1 is likely to explain inhibition of PFK-I and of glycolysis. However, at 20 mM-glucose, the inhibition of lactate release by palmitate was greater than the effect on [3-3H]glucose detritiation. The difference does not necessarily imply that steps downstream from PFK-1 should be regulated by palmitate. Indeed, it may be explained by the occurrence ofmetabolite cycling through PFK-1 and fructose-1,6-bisphosphatase (FBPase-1). The cycling rate could be as large as the difference between the rates of [3-3H]glucose detritiation, which gives an estimation of PFK-1 flux, and lactate release (expressed in the same units). The difference between [3-3H]glucose detritiation and lactate release was equal to about 9 /imol of glucose/45 min per g of hepatocytes, and was not influenced by palmitate. In the absence of palmitate, the difference was roughly equal to lactate release, whereas with palmitate it was at least 5 times larger. Thus the latter condition favours gluconeogenesis. Alternatively, the difference between detritiation and lactate release might have been caused by the utilization of sn-glycerol 3-phosphate for the esterification of palmitate. The latter condition is characterized by an elevated concentration of sn-glycerol 3-phosphate [27] that was also observed under our conditions (Table 1) .
Regarding the mechanisms involved in decreasing Fru-2,6-P2 concentrations, changes in the activation of PFK-2/FBPase-2 can be ruled out, since palmitate did not induce changes in the activity of the bifunctional enzyme (results not shown). On the other hand, the data of Table 1 suggest that the increased concentrations of citrate and sn-glycerol 3-phosphate (both inhibit PFK-2, and the latter also stimulates FBPase-2 [1, 2] Citrate concn. (mM) Fig. 3 . Inhibition by citrate of PFK-2 purified from rat liver and bovine heart
The activity was measured at pH 7.1 in the presence of 0.1 mM-fructose 6-phosphate, 0.3 mM-glucose 6-phosphate, 5 mM-MgATP and 5 mM-potassium phosphate, and was equal to 33 (liver; 0) and 250 -(heart; El) nmol/min per mg of protein under control conditions. citrate of PFK-2 purified from rat liver and heart is illustrated in Fig. 3 [23, 28] . They should be compared with the cytosolic concentrations of citrate. These are difficult to evaluate, because of compartmentation and possible binding to proteins. In hepatocytes, the cytosolic content represents about 50 0 of the total citrate with a mitochondrial/cytosolic gradient of 10 or more [29] . Inhibition of heart glycolysis by ketone bodies Fatty acid and ketone bodies are known to inhibit glucose utilization in heart in vitro [3, 4] . This led to the concept of the glucose/fatty acid cycle, which explains the glucose-sparing effect of fatty acids and ketone bodies [5] . The inhibition of glucose utilization by cardiac muscle is explained, at least in part, by an inhibition of PFK-I by citrate, whose concentration in increases during fatty acid oxidation [30] .
We have confirmed these observations ( Table 2 ), namely that perfusion of hearts from fed ( (Fig. 3 ) are similar to those measured in perfused hearts ( Table 2) . As for hepatocytes, the concentration of cytosolic citrate is difficult to evaluate. It is proposed that, as in liver, citrate inhibits both PFK-1 and PFK-2. Inhibition of the latter lowers Fru-2,6-P2 concentration, and so reinforces the inhibition of PFK-1 by citrate.
Conclusions
The demonstration that fatty acids inhibit glycolysis not only in muscle, but also in liver, extends to this organ the concept of the glucose/fatty acid cycle. Whether this contributes much to glucose sparing for the whole animal is unlikely, since the proportion of body glucose that is glycolysed in the liver is relatively small. However, by inhibiting glucokinase and, mainly, PFK-1, fatty acids set the liver in gluconeogenic conditions. Therefore, the inhibition of glycolysis further adds to the wellknown stimulation of pyruvate carboxylase by acetylCoA derived from fatty acids [31] , and so works towards a concerted mechanism for the stimulation of gluconeogenesis.
Fatty acids, like relatively large concentrations of gluconeogenic precursors such as lactate, pyruvate and alanine, decrease the concentration of Fru-2,6-P2 in the liver. During aerobiosis, Fru-2,6-P2 could be regarded as a glycolytic signal which is turned on by glucose availability and switched off by alternative fuels. Moreover, in heart, as in the muscles of flying locusts [32] , a fall in Fru-2,6-P2 concentration could signal the presence of non-glycolytic substrates and, by doing so, it can contribute to the glucose-sparing effect of these substrates. In these tissues, the increased citrate concentration probably plays a crucial role in inhibiting PFK-1 and PFK-2.
